Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? News, features, and commentary about cancer-related issues Jun 13, 2024
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers Jun 13, 2024
Tanning Salons Are Overdue for a Regulatory Burn In the meantime, don't forget to educate patients on the risks Jun 13, 2024
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer No difference in PFS, median OS favored control group Jun 12, 2024
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer Half of patients responded, but editorialists call for new directions in therapy development Jun 11, 2024
Middle-Age Man Presents With Necrotizing Mass on Nose Rare condition can be deadly without early diagnosis and treatment Jun 10, 2024
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma Immunotherapy may have been given too late, researchers suggested Jun 10, 2024
Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South But one study showed that patient navigation added to usual care may increase uptake Jun 10, 2024
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
Telomerase Inhibitor Approved for MDS-Related Anemia Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
Search for Missing Doctor; Energy Drinks and Sudden Death; Unusual Pandemic Cancers Health news and commentary gathered by MedPage Today staff Jun 07, 2024
Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Shows Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial News, features, and commentary about cancer-related issues Jun 06, 2024
Metformin Fails to Stop Early Prostate Cancer Progression Study suggests it may even be detrimental in some groups of patients on active surveillance Jun 05, 2024
Docetaxel Tied to Less Taxane Neuropathy in Black Breast Cancer Patients Dose-limiting toxicity has been linked with worse outcomes specifically in this population Jun 05, 2024
Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brains Health news and commentary gathered by MedPage Today staff Jun 05, 2024
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma Two trials show positive outcomes Jun 04, 2024
Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma A third as many clinical events versus adjuvant therapy, 6 weeks of treatment for many patients Jun 04, 2024
ctDNA Analysis Not Enough to Guide Chemo De-Escalation in Early Pancreatic Cancer Adjuvant chemo de-escalation based on ctDNA had no effect on recurrence-free survival Jun 04, 2024
A Win for Liver Transplantation in Unresectable Metastatic Colorectal Cancer Three new trials address CRC liver metastases Jun 04, 2024
New Drug Effective for Tenosynovial Giant Cell Tumors, and With No Liver Concerns Current option for rare tumor requires a REMS to monitor for drug-induced liver injury Jun 04, 2024
Industry Clinic • Ad Insights What Will It Take to Deliver Both Health & Care in Oncology? Jun 04, 2024
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers Clear cell histology "is what yields the super response we see in these trials," expert suggests Jun 04, 2024
IRS Sues Controversial Doctor; Congresswoman Has Cancer; Caffeine and Teens Health news and commentary gathered by MedPage Today staff Jun 04, 2024
Cheap Drug Eases Hot Flashes in Men With Prostate Cancer Anticholinergic oxybutynin for patients taking ADT also improved quality of life in the process Jun 03, 2024
Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group Jun 03, 2024
Perioperative Chemo Extends Survival in Resectable Esophageal Cancer Improvement also observed in complete remission rates with FLOT over CROSS regimen Jun 03, 2024
Lymphadenectomy Not Needed in Advanced Ovarian Cancer With Optimal Surgery PFS was not significantly different for those who skipped lymphadenectomy Jun 03, 2024
Triplet Notches Survival Win in Heavily Pretreated DLBCL Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant Jun 02, 2024
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer Trastuzumab deruxtecan extended its superiority versus chemotherapy into HER2-ultralow Jun 02, 2024
Novel CD40 Agonist-Chemo Combo Shows Promise in Pancreatic Cancer Frontline treatment with mitazalimab plus mFOLFIRINOX achieved responses in 40% of patients Jun 02, 2024
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
Intralesional Therapy for Melanoma Effective, May Have Systemic Activity Preoperative antibody fusion daromun significantly reduced relapse versus upfront surgery Jun 02, 2024
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma Second belantamab mafodotin-containing triplet to show potency in this setting Jun 02, 2024
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer No differences observed in quality of life metric, patient and caregiver satisfaction Jun 02, 2024
Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC Unexpectedly offers a possible overall survival benefit, researchers say Jun 01, 2024
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents China-based trial may present a hurdle to FDA approval, however Jun 01, 2024
